Literature DB >> 12594286

Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.

Melissa L Precopio1, John L Sullivan, Courtney Willard, Mohan Somasundaran, Katherine Luzuriaga.   

Abstract

The generation and maintenance of virus-specific CD4(+) T cells in humans are not well understood. We used short in vitro stimulation assays followed by intracellular cytokine staining to characterize the timing, magnitude, and Ag specificity of CD4(+) T cells over the course of primary EBV infection. Lytic and latent protein-specific CD4(+) T cells were readily detected at presentation with acute infectious mononucleosis and declined rapidly thereafter. Responses to BZLF-1, BMLF-1, and Epstein-Barr nuclear Ag-3A were more commonly detected than responses to Epstein-Barr nuclear Ag-1. Concurrent analyses of BZLF-1-specific CD4(+) and CD8(+) T cells revealed differences in the expansion, specificity, and stability of CD4(+) and CD8(+) T cell-mediated responses over time. Peripheral blood EBV load directly correlated with the frequency of EBV-specific CD4(+) T cell responses at presentation and over time, suggesting that EBV-specific CD4(+) T cell responses are Ag-driven.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594286     DOI: 10.4049/jimmunol.170.5.2590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.

Authors:  Catherine Riou; Vitaly V Ganusov; Suzanne Campion; Mandla Mlotshwa; Michael K P Liu; Victoria E Whale; Nilu Goonetilleke; Persephone Borrow; Guido Ferrari; Michael R Betts; Barton F Haynes; Andrew J McMichael; Clive M Gray
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

2.  HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays.

Authors:  Jennifer D Stone; Walter E Demkowicz; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

3.  Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.

Authors:  J Scherrenburg; E R W A N Piriou; N M Nanlohy; D van Baarle
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

Review 4.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.

Authors:  Alex S Hartlage; Tom Liu; John T Patton; Sabrina L Garman; Xiaoli Zhang; Habibe Kurt; Gerard Lozanski; Mark E Lustberg; Michael A Caligiuri; Robert A Baiocchi
Journal:  Cancer Immunol Res       Date:  2015-03-03       Impact factor: 11.151

6.  CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells.

Authors:  John J Zaunders; Wayne B Dyer; Mee Ling Munier; Susanna Ip; Jie Liu; Elisabeth Amyes; William Rawlinson; Robert De Rose; Stephen J Kent; John S Sullivan; David A Cooper; Anthony D Kelleher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.

Authors:  Thomas C Greenough; Shalyn C Campellone; Robin Brody; Surbhi Jain; Victor Sanchez-Merino; Mohan Somasundaran; Katherine Luzuriaga
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.

Authors:  Nicholas Renzette; Mohan Somasundaran; Frank Brewster; James Coderre; Eric R Weiss; Margaret McManus; Thomas Greenough; Barbara Tabak; Manuel Garber; Timothy F Kowalik; Katherine Luzuriaga
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

9.  Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.

Authors:  G Gallot; S Vollant; R Vivien; B Clémenceau; C Ferrand; P Tiberghien; J Gaschet; N Robillard; H Vié
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines.

Authors:  Sumita Bhaduri-McIntosh; Marisa J Rotenberg; Benjamin Gardner; Marie Robert; George Miller
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.